BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

  September 18, 2025

   · 

  1 min read
• Press Releases

  Vaxart Appoints W. Mark Watson as Lead Independent Director

  September 18, 2025

   · 

  6 min read
• Press Releases

  Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

  September 18, 2025

   · 

  7 min read
• Press Releases

  NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

  September 18, 2025

   · 

  9 min read
• Press Releases

  Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

  September 18, 2025

   · 

  2 min read
• Press Releases

  CooperCompanies Announces Expanded Share Repurchase Program

  September 18, 2025

   · 

  2 min read
• Press Releases

  Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome

  September 18, 2025

   · 

  3 min read
• Press Releases

  Biosensing Instrument Introduces SPRm 220 Series Cell-Based Surface Plasmon Resonance Microscopy System

  September 18, 2025

   · 

  1 min read
• Press Releases

  ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer

  September 18, 2025

   · 

  2 min read
• Press Releases

  Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

  September 18, 2025

   · 

  5 min read